A clinical trial to find the action of individualized homoeopathic LM potencies in the treatment of grade-2 and grade-3 fatty liver disease in non-alcoholic patients
Phase 2
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2023/11/060254
- Lead Sponsor
- Dr Smriti Debbarma, PG scholar department of practice of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Non-alcoholic patients
Patients with elevated serum ALT more than 50 U/L
Ultrasonographically diagnosed cases of grade 2 and grade 3 non-alcoholic fatty liver disease
Exclusion Criteria
Subjects with history of drug intake known to result in liver enzyme elevation
Patients with complications of like liver cirrhosis, hepatocellularcarcinoma.
Patients with cholelithiasis & cholecystitis.
Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method